Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

OBJECTIVE: Nonalcoholic fatty liver disease is highly prevalent in obese and type 2 diabetic individuals and is strongly associated with dyslipidemia and inflammation. Weight loss and/or pharmacotherapy are commonly used to correct these abnormalities. RESEARCH DESIGN AND METHODS: We performed a 16-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Dick C., Watts, Gerald F., Gan, Seng Khee, Ooi, Esther M.M., Barrett, P. Hugh R.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858190/
https://www.ncbi.nlm.nih.gov/pubmed/20185740
http://dx.doi.org/10.2337/dc09-1765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858190/
https://www.ncbi.nlm.nih.gov/pubmed/20185740
http://dx.doi.org/10.2337/dc09-1765

Ejemplares similares